ASO Author Reflections: Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9.

Yamanaka, Masaya; Hayashi, Masamichi; Kodera, Yasuhiro

Yamanaka, Masaya; Hayashi, Masamichi; Kodera, Yasuhiro.

Afiliação

Yamanaka M; Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan.
Hayashi M; Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan. m-hayashi@med.nagoya-u.ac.jp.
Kodera Y; Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan.

Ann Surg Oncol ; 29(11): 7190-7191, 2022 10.

Article em En | MEDLINE | ID: mdl-35767102

Assuntos

Metaloproteinase 9 da Matriz; Neoplasias Pancreáticas; Biomarcadores; Movimento Celular; Proliferação de Células; Regulação para Baixo; Humanos; Prognóstico; Receptores de Superfície Celular; Neoplasias Pancreáticas

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Metaloproteinase 9 da Matriz Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google